IADSA update on international supplement regulations

AHPA Alerts

AHPA Alerts

AHPA keeps members and the industry informed of recent news and developments that impact the trade through email alerts. Subscribe to news as it happens or a weekly summary of all alerts.

Subscribe

View recent alerts:

  • Legal Alerts News on dietary supplement laws, regulations and enforcement
  • Science Alerts The latest research on herbs and botanicals
  • Market Alerts Herbal market trends and AHPA-member press releases
  • Media Alerts Media coverage of the herbal industry 
  • Cannabis Alerts The latest research and news about hemp, CBD and medical marijuana
  • Cosmetic Alerts Regulatory updates and personal care product news

Subscribe to AHPA Updates to stay informed about the latest AHPA news and resources.

Recent News

IADSA update on international supplement regulations

IADSA February 2019 Newsflash

Published: Friday, March 15, 2019

AHPA is an active member of IADSA and is distributing the IADSA Newsflash as a member benefit. IADSA is an association focused on the globalization of food supplement markets and regulatory challenges. This issue of the IADSA Newsflash covers:

  • The ongoing challenge of developing workable regulations for food supplement claims
  • China is currently undertaking a cleanup of its healthcare industry following the death of a pediatric cancer patient taking herbal products
  • India issued a final decision to discontinue use of 14 food supplement ingredients due to lack of information supporting safe use in India for 15 years
  • Taiwan has made progress toward the legal recognition of food supplements as a product category
  • The EU has banned yohimbe and its preparations after it was put under scrutiny in 2015
  • The EU is consulting on regulatory limits for pyrrolizidine alkaloids in teas, honey, and food supplement products
  • Extracts of hemp containing cannabinoids such as cannabidiol are classified as novel foods in the EU
  • The EC has suspended claims for red yeast rice products pending a decision on the safety of the product
  • France is considering a ban on titanium dioxide pending a safety review of nanoparticles

Download the February 2019 issue >>

Print

2022 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.